Kenvue solves the battle of proxy with activist starboard, Sources CNBC


Kenvue CEO Thibaut Mong Mong, May 4, 2023, on the New York Exchange for the initial public presentation.

Source: nyse

Ram The activist solved the proxy battle with Starboard value, Sources say CNBC’s David Faber.

Starboard’s Jeff Smith, Johnson & Johnson will join the Spinoff’s board, and not with two new independent directors.

Kenvue is a manufacturer of widespread brands familiar with both investors, investors, both investors, listerin, Neutrogena, Neutrogena, Tylenol and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J. J & J completed the separation from Kenvue in August 2023, but the drug company still owns a share in the giant of consumer goods.

Sources told CNBC to CNBC in October collected a significant share The company was disappointed in the performance of the management and share price.

This is the news. Please update updates.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *